APPLICATION
ANDA214180
TYPE
ANDA
ORIGINAL APPROVAL
2021-11-19
LATEST ACTION
2024-03-20
ROUTE
ORAL
DOSAGE FORM
GRANULE
MARKETING STATUS
Discontinued
Products
DEFERASIROXDiscontinued
DEFERASIROX 360MG · GRANULE · ORAL
DEFERASIROXDiscontinued
DEFERASIROX 90MG · GRANULE · ORAL
DEFERASIROXDiscontinued
DEFERASIROX 180MG · GRANULE · ORAL
Approval history
2024-03-20Labeling · Supplement 5 · standardAP
2023-04-07Labeling · Supplement 4 · standardAP
2023-04-07Labeling · Supplement 1 · standardAP
2021-11-19UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.